MINNEAPOLIS--(BUSINESS WIRE)--Kips Bay Medical (NASDAQ: KIPS) today announced that the United States Patent and Trademark Office (USPTO) has issued to the Company patent number 7,998,188, titled “Compliant Blood Vessel Graft,” which includes eleven permitted claims covering the Company’s core eSVS® MESH technology, and represents the first patent obtained in the United States covering this technology. The USPTO has also issued a Notice of Allowance approving a second patent application, titled “Compliant Venous Stent,” which includes three claims related to the eSVS MESH design.
